Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Ulcerative Colitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05668013
What this trial is testing

Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Who this might be right for
Crohn DiseaseColitis, Ulcerative
Teva Branded Pharmaceutical Products R&D LLC 247
Large-scale testing (Phase 3)Study completedNCT02171429
What this trial is testing

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Ulcerative Colitis
Hoffmann-La Roche 358
Testing effectiveness (Phase 2)Ended earlyNCT03650413
What this trial is testing

An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Genentech, Inc. 143
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07535489
What this trial is testing

Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2)

Who this might be right for
Moderately to Severely Active Ulcerative Colitis (UC)
Nanjing Immunophage Biotech Co., Ltd 144
Testing effectiveness (Phase 2)Study completedNCT05377580
What this trial is testing

Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Innovent Biologics (Suzhou) Co. Ltd. 150
Early research (Phase 1)Study completedNCT02818686
What this trial is testing

TD-1473 for Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe
Theravance Biopharma 40
Large-scale testing (Phase 3)Study completedNCT03524092
What this trial is testing

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 1,328
Not applicableUnknownNCT02277470
What this trial is testing

Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20
Large-scale testing (Phase 3)Study completedNCT05507216
What this trial is testing

ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

Who this might be right for
Ulcerative Colitis
Abivax S.A. 636
Large-scale testing (Phase 3)Looking for participantsNCT04844606
What this trial is testing

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Who this might be right for
Ulcerative ColitisUlcerative Colitis ChronicInflammatory Bowel Diseases+1 more
Eli Lilly and Company 150
Not applicableUnknownNCT06469424
What this trial is testing

An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)

Who this might be right for
Ulcerative Colitis
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 104
Not applicableUnknownNCT04879966
What this trial is testing

A Cohort Study Comparing IFX to CS for Moderate to Severe UC

Who this might be right for
Moderate to Severe Ulcerative Colitis
Sixth Affiliated Hospital, Sun Yat-sen University 342
Testing effectiveness (Phase 2)Study completedNCT02447302
What this trial is testing

Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Arena Pharmaceuticals 156
Large-scale testing (Phase 3)Study completedNCT02665845
What this trial is testing

Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).

Who this might be right for
Ulcerative Colitis
Centre Hospitalier Universitaire de Saint Etienne 160
Post-approval studies (Phase 4)Study completedNCT06626165
What this trial is testing

Association Between Effectiveness of Mirikizumab and UC Patients With High Neutrophilic Infiltration in Epithelium of the Colonic Mucosa

Who this might be right for
Ulcerative Colitis
Showa Inan General Hospital 100
Early research (Phase 1)Not Yet RecruitingNCT07747467
What this trial is testing

Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
GlaxoSmithKline 16
Large-scale testing (Phase 3)Active Not RecruitingNCT03596645
What this trial is testing

Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 84
Not applicableEnded earlyNCT07653750
What this trial is testing

Study on Variation of Serum and Fecal Biomarkers After Treatment to Predict Mucosal Healing in Patients With Ulcerative Colitis

Who this might be right for
Moderate to Severe Ulcerative Colitis
University Hospital, Clermont-Ferrand 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT06867094
What this trial is testing

Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

Who this might be right for
Colitis Ulcerative
Sanofi 204
Testing effectiveness (Phase 2)Study completedNCT03662542
What this trial is testing

Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 214
Next Page